PHRX — Pharmadrug Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Pharmadrug, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS/A	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-6.54	-5.43	-4.28	-3.06	-13.3
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	3.47	3.06	0.272	0.889	13.3
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	0.395	-0.252	-0.133	0.087	0.294
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-2.34	-1.8	-4.13	-2.26	-0.672
Capital Expenditures	-0.019	-0.018	-0.043	—	—
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7.3	3.8	1.52	0.078	0.995
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7.32	3.78	1.48	0.078	0.995
Financing Cash Flow Items	4.14	-0.062	-0.177	-0.145	0.222
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	9.51	0.132	0.777	0.843	0.226
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.081	2.06	-1.18	-0.949	0.552